Hims & Hers fell 16.6% after earnings, as investors appear to have focused on management’s planned trade-off of near-term subscriber growth for longer-term positioning. The company said it pulled back on weight-loss marketing and will redeploy investment ahead of the new year, while emphasizing future opportunities rather than near-term growth.
Shares declined 3.4% as market participants reacted negatively to signs of deceleration in a key growth metric and cautious management tone despite strategic investments in AI. Investor concerns likely centered on the forward outlook ambiguities and the absence of explicit margin or revenue acceleration details.
Shares dropped 11.5% following earnings as investors reacted negatively to a cautious outlook on growth and margin pressures despite commentary on platform expansion and new product introductions.
Hims & Hers reported a robust Q3 2025, achieving nearly 50% year-over-year revenue growth driven by a 50% increase in subscribers using personalized health solutions, bolstered by strategic partnerships and innovations.